HOUSE BILL No. 4019 January 26, 1999, Introduced by Rep. Rocca and referred to the Committee on Health Policy. A bill to amend 1978 PA 368, entitled "Public health code," by amending section 7216 (MCL 333.7216). THE PEOPLE OF THE STATE OF MICHIGAN ENACT: 1 Sec. 7216. (1) The following controlled substances are 2 included in schedule 3: 3 (a) Unless listed in another schedule, any material, com- 4 pound, mixture, or preparation CONTAINING ANY QUANTITY OF THE 5 FOLLOWING SUBSTANCES HAVING A POTENTIAL FOR ABUSE ASSOCIATED WITH 6 A STIMULANT EFFECT ON THE CENTRAL NERVOUS SYSTEM, includingits7 THEIR salts, isomers,(whetherINCLUDING optical, position, or 8 geometric)ISOMERS, and salts of the isomerswhenIF the 9 existence of the salts, isomers, and salts of isomers is possible 10 within the specific chemical designation:as listed in schedule113, which contains any quantity of the following substances having00533'99 JOJ 2 1a potential for abuse associated with a stimulant effect on the2central nervous system:3 4 Benzphetamine Mediatric tabs 5 Chlorphentermine Mediatric liquid 6 Clortermine Phendimetrazine 7 Edrisal tabs Special formula 711 tabs 8 Genegesic caps Thora Dex No. 1 tab 9 Hovizyme tabs Thora Dex No. 2 tab 10 Mazindol 11 (b) Unless listed in another schedule, any material, com- 12 pound, mixture, or preparation CONTAINING ANY QUANTITY OF THE 13 FOLLOWING SUBSTANCES HAVING A POTENTIAL FOR ABUSE ASSOCIATED WITH 14 A DEPRESSANT EFFECT ON THE CENTRAL NERVOUS SYSTEM, including 15itsTHEIR salts, isomers,(whetherINCLUDING optical, posi- 16 tion, or geometric)ISOMERS, and salts of the isomerswhen17 IF the existence of the salts, isomers, and salts of isomers is 18 possible within the specific chemical designation:as listed in19schedule 3, which contains any quantity of the following sub-20stances having a potential for abuse associated with a depressant21effect on the central nervous system:22 23 Chlorhexadol Phencyclidine 24 Glutethimide Sulfondiethylmethane 25 Lysergic acid Sulfonethylmethane 26 Lysergic acid amide Sulfonmethane 00533'99 3 1 Methyprylon 2 (c) Nalorphine. 3 (d) Any substancewhichTHAT contains any quantity of a 4 derivative of barbituric acid, or any salt of a derivative of 5 barbituric acid, except those substanceswhichTHAT are specif- 6 ically listed in other schedules. 7 (e) A compound, mixture, or preparation containing amobarbi- 8 tal, secobarbital, pentobarbital, oranyA saltthereofOF 9 AMOBARBITAL, SECOBARBITAL, OR PENTOBARBITAL, and 1 or more other 10 active medicinal ingredientswhichTHAT are not listed in a 11 schedule. 12 (f) A suppository dosage form containing amobarbital, seco- 13 barbital, pentobarbital, or a salt ofany of these drugs14 AMOBARBITAL, SECOBARBITAL, OR PENTOBARBITAL and approved by the 15 food and drug administration for marketing only as a 16 suppository. 17 (g) Any material, compound, mixture, or preparation contain- 18 ing limited quantities of any of the following narcotic drugs or 19anyTHEIR salts:thereof:20 (i) Not more than 1.8 grams of codeine, or any of its salts, 21 per 100 milliliters or not more than 90 milligrams per dosage 22 unit, with an equal or greater quantity of an isoquinoline alka- 23 loid of opium. 24 (ii) Not more than 1.8 grams of codeine, or any of its 25 salts, per 100 milliliters or not more than 90 milligrams per 26 dosage unit, with 1 or more active,nonnarcotic ingredients in 27 recognized therapeutic amounts. 00533'99 4 1 (iii) Not more than 300 milligrams of dihydrocodeinone, or 2 any of its salts, per 100 milliliters or not more than 15 milli- 3 grams per dosage unit, with a fourfold or greater quantity of an 4 isoquinoline alkaloid of opium. 5 (iv) Not more than 300 milligrams of dihydrocodeinone, or 6 any of its salts, per 100 milliliters or not more than 15 milli- 7 grams per dosage unit, with 1 or more active,nonnarcotic 8 ingredients in recognized therapeutic amounts. 9 (v) Not more than 1.8 grams of dihydrocodeine, or any of its 10 salts, per 100 milliliters or not more than 90 milligrams per 11 dosage unit, with 1 or more active nonnarcotic ingredients in 12 recognized therapeutic amounts. 13 (vi) Not more than 300 milligrams of ethylmorphine, or any 14 of its salts, per 100 milliliters or not more than 15 milligrams 15 per dosage unit, with 1 or more ingredients in recognized thera- 16 peutic amounts. 17 (vii) Not more than 500 milligrams of opium per 100 millili- 18 ters or per 100 grams, or not more than 25 milligrams per dosage 19 unit, with 1 or more active,nonnarcotic ingredients in recog- 20 nized therapeutic amounts. 21 (viii) Not more than 50 milligrams of morphine, or any of 22 its salts, per 100 milliliters or per 100 grams, with 1 or more 23 active,nonnarcotic ingredients in recognized therapeutic 24 amounts. 25 (H) ANY MATERIAL, COMPOUND, MIXTURE, OR PREPARATION CONTAIN- 26 ING ANY QUANTITY OF KETAMINE, A SALT OF KETAMINE, AN ISOMER OF 27 KETAMINE, OR A SALT OF AN ISOMER OF KETAMINE. 00533'99 5 1 (2) The administrator may promulgate rules to except a 2 compound, mixture, or preparation containing any stimulant or 3 depressant substance listed in subsection (1)(a) and (b) from the 4 application of all or any part of this article if the compound, 5 mixture, or preparation contains 1 or more active medicinal 6 ingredients not having a stimulant or depressant effect on the 7 central nervous system,and if the admixtures areincluded8thereinin combinations, quantity, proportion, or concentration 9 that vitiate the potential for abuse of the substanceswhich10haveHAVING a stimulant or depressant effect on the central ner- 11 vous system. 00533'99 Final page. JOJ